$2.47
0.3818.18%
Last update: Nov 3, 6:18 PM
Alterity Therapeutics Ltd (ATHE) Stock Price, Quote, News & History
ATHENASDAQ
Alterity Therapeutics secured a USPTO patent for ATH434, extending market protection for its neurodegenerative drug candidate to 2045.
You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Alterity Therapeutics has a consensus price target of $10.67.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $2.45 last updated November 3, 2026 at 6:18 PM EST.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's...
